Mifepristone as Adjunctive Therapy in Alzheimer's Disease

NCT00105105 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Mifepristone

Sponsor

Corcept Therapeutics

Collaborators

[object Object]